66 /100
HIGH RISK
Score updated Jul 14, 2026

RENEF — Cartesian Growth Corporation II Dilution Risk Tracker

Track RENEF dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track RENEF — Get alerts when the score changes →

As of July 14, 2026, Cartesian Growth Corporation II (RENEF) has a DilutionWatch DilutionScore of 66/100, rated HIGH dilution risk. Cartesian Growth Corporation II has a market capitalization of $165.23M, 5.75M shares outstanding, 1 institutional holders tracked. Key dilution vectors include 16.57M outstanding warrants, approximately 2 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
95
📊 Float Risk
77
⚠️ Warrant Exposure
90
🔄Convertible Debt

🌦️ Dilution Forecast

⛈️
Warning
High probability of dilution event
48%
📜 Warrant Exercise 60%
• Massive warrant overhang: 288% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise 55%
• Critical: only 2.5 months cash remaining
📉 Score Deterioration 10%
• Score in HIGH risk zone (66/100)
🔔 Track RENEF — Get forecast alerts →

💹 Market Data

Market Cap$165.23M
Shares Outstanding5.75M
Float1.83M
Cash$105.3K
Debt$9.24M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↓ 69.0% shares (2026Q1 vs prior)
1 institutional holders · 43.5K shares
#1 BARCLAYS PLC 43.5K shares

📉 Short Interest

Short Interest14
Days to Cover1000.0
% of FloatN/A
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Mar 31, 2026
xbrl XBRL CONVERTIBLE Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for RENEF Shareholders

Cartesian Growth Corporation II (RENEF) has a DilutionScore of 66/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 14, 2026, updated from SEC EDGAR data.

DilutionWatch tracks 16.6M outstanding warrants for RENEF. Warrants become dilutive when exercised — converting to common shares at the strike price. Warrants near or in-the-money deserve particular attention since exercise can add materially to the outstanding share count within a short window. Cash runway is a key watch item: RENEF has approximately 2 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for RENEF in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for RENEF alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Warrants Explained →
Track RENEF Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking RENEF — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for RENEF
📊 RENEF FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 RENEF Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.